• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Eurofarma - Product Pipeline Review - Q2 2011 Product Image

Eurofarma - Product Pipeline Review - Q2 2011

  • Published: July 2011
  • 40 pages
  • Global Markets Direct

Eurofarma – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Eurofarma - Product Pipeline Review - Q2 2011” provides data on the Eurofarma’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Eurofarma’s corporate website, SEC filings, investor presentations and featured press releases, both from Eurofarma and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Eurofarma - Brief Eurofarma overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Eurofarma human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- READ MORE >



List of Tables
List of Figures
Eurofarma Snapshot
Eurofarma Overview
Key Information
Key Facts
Eurofarma – Research and Development Overview
Key Therapeutic Areas
Eurofarma – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Eurofarma – Pipeline Products Glance
Eurofarma – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Eurofarma Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Eurofarma – Drug Profiles
Dexalgen
Product Description
Mechanism of Action
R&D Progress
Diupress
Product Description
Mechanism of Action
R&D Progress
Diurisa
Product Description
Mechanism of Action
R&D Progress
Eszopiclone
Product Description
Mechanism of Action
R&D Progress
Filgrastim
Product Description
Mechanism of Action
R&D Progress
Formoterol + Fluticasone
Product Description
Mechanism of Action
R&D Progress
Glucosamine + Chondroitin
Product Description
Mechanism of Action
R&D Progress
Heparin Sodium
Product Description
Mechanism of Action
R&D Progress
Heptar
Product Description
Mechanism of Action
R&D Progress
Nimotuzumab + Cisplatin + Fluorouracil + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Salmeterol + Fluticasone
Product Description
Mechanism of Action
R&D Progress
Symbicort
Product Description
Mechanism of Action
R&D Progress
Nimotuzumab + Cisplatin + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Nimotuzumab + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Symbicort
Product Description
Mechanism of Action
R&D Progress
Eurofarma – Pipeline Analysis
Eurofarma – Pipeline Products by Therapeutic Class
Eurofarma - Pipeline Products By Target
Eurofarma – Pipeline Products by Route of Administration
Eurofarma – Pipeline Products by Molecule Type
Eurofarma – Recent Pipeline Updates
Eurofarma – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Eurofarma – Pipeline by Therapy Area and Indication, 2011
Eurofarma – Pipeline by Stage of Development, 2011
Eurofarma – Monotherapy Products in Pipeline, 2011
Eurofarma – Combination Treatment Modalities in Pipeline, 2011
Eurofarma – Phase III, 2011
Eurofarma - Phase II, 2011
Eurofarma - Pipeline By Therapeutic Class, 2011
Eurofarma - Pipeline By Target, 2011
Eurofarma – Pipeline By Route of Administration, 2011
Eurofarma – Pipeline By Molecule Type, 2011
Eurofarma – Recent Pipeline Updates, 2011
Eurofarma, Other Locations

List of Figures
Eurofarma – Pipeline by Therapy Area and Indication, 2011
Eurofarma – Pipeline by Stage of Development, 2011
Eurofarma – Monotherapy Products in Pipeline, 2011
Eurofarma – Combination Treatment Modalities in Pipeline, 2011
Eurofarma – Pipeline By Therapeutic Class, 2011
Eurofarma - Pipeline By Target, 2011
Eurofarma – Pipeline By Route of Administration, 2011
Eurofarma – Pipeline By Molecule Type, 2011

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS